Stock Analysis

Zhejiang Qianjiang Biochemical Second Quarter 2024 Earnings: EPS: CN¥0.062 (vs CN¥0.058 in 2Q 2023)

Published
SHSE:600796

Zhejiang Qianjiang Biochemical (SHSE:600796) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥488.7m (down 4.1% from 2Q 2023).
  • Net income: CN¥53.5m (down 1.2% from 2Q 2023).
  • Profit margin: 11% (in line with 2Q 2023).
  • EPS: CN¥0.062.
SHSE:600796 Earnings and Revenue History August 28th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Zhejiang Qianjiang Biochemical shares are up 2.0% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on Zhejiang Qianjiang Biochemical's balance sheet.

Valuation is complex, but we're here to simplify it.

Discover if Zhejiang Qianjiang Biochemical might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.